Pharma Reviews: Markets end higher for fifth straight session; Sensex, Nifty surge 1.3% each

Jubilant Generics has received approval from the Drug Controller General of India to manufacture and market investigational drug Remdesivir 100 ...
Read more: Markets end higher for fifth straight session; Sensex, Nifty surge 1.3% each